Skip to content
★ Sign in to follow
인바

인바이츠바이오코아 Stock: price and insider trades · South Korea

No insider purchase over the last 90 days. The latest, by 신승수, was filed 30 Jul 2026.

인바이츠바이오코아: what insiders have been doing

인바이츠바이오코아 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). In the past year (10 November 2025 to 10 November 2026), 6 filings came from 3 insiders.

Purchases and sales both appear in the filings: 5 purchases (2 insiders) and 1 sale (1 insider). The totals do not cover 6 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 chief executive.

For context, the typical company on the same exchange (median of 2,648 companies) published 7 filings over the same period, against 6 filings here. Since 2021, the database holds 8 purchases and 2 sales by insiders of the company.

The last insider purchase was made public on 30 July 2026, 103 days ago.

In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Insider Decl.
12
Thresholds
n/a
Buy Volume
n/a
8 ops. · all time
Sell Volume
n/a
2 ops. · all time

Who traded when

BuySale
신승수5 buys
에스비아이-성장사다리 코넥스 활성화펀드1 sale
인바이츠지노믹스1 buy

Financial data

· cache

Last declaration on 30 July 2026
Declarations15 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    Executives(filed)
    0DART
    10,000 sharesShareKRXDART:20260730000482
    Canonical exit: 28 Oct 2026 (T+90)
  • ▲
    Executives(filed)
    0DART
    35,000 sharesShareKRXDART:20260722000379
    Canonical exit: 20 Oct 2026 (T+90)
  • ▼
    대량보유자Executives(filed)
    0DART
    264,512 sharesKRXDART:20260716000608
  • ▲
    Executives(filed)
    0DART
    52,220 sharesShareKRXDART:20260119000087
    Canonical exit: 19 Apr 2026 (T+90)
  • ▲
    Executives(filed)
    0DART
    2,000 sharesShareKRXDART:20251209000043
    Canonical exit: 9 Mar 2026 (T+90)
  • ▲
    Executives(filed)
    0DART
    2,000 sharesShareKRXDART:20251202000156
    Canonical exit: 2 Mar 2026 (T+90)
  • ▲
    Executives(filed)
    0DART
    9,300 sharesShareKRXDART:20251105000103
    Canonical exit: 3 Feb 2026 (T+90)
  • ▼
    Executives(filed)
    0DART
    395,145 sharesKRXDART:20221109000358
  • ▲
    Executives(filed)
    0DART
    216,963 sharesKRXDART:20220330000715
    Canonical exit: 28 Jun 2022 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    대표이사Executives(filed)
    0DART
    ShareKRXDART:20210407001212
    Canonical exit: 6 Jul 2021 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART

15 of 15 declarations

About 인바이츠바이오코아

InVitesBioCore is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions in the biotechnology field.